Victoria Newton1, William McGuire2, Rachel Wills1, Gerry Lowe1, and N. Jane Taylor2
1Radiotherapy Physics, Mount Vernon Hospital, Northwood, United Kingdom, 2Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, United Kingdom
Synopsis
Interstitial brachytherapy needles in High
Dose Rate radiotherapy patients can be visualised clearly and accurately within
clinical tolerance values using just a proton-density StarVIBE sequence instead
of registered CT and MR images. This could lead to a reduced radiation dose
MR-only workflow without compromising the quality of treatment and a reduction
of errors in image registration.
Introduction
MRI is currently used with CT for HDR (High Dose Rate) brachytherapy
treatment planning at this centre. Applicator reconstruction is performed on CT
images, but OARs (Organs At Risk) and the CTV (Clinical Target Volume) are
delineated primarily on MRI. We wish
to image these patients solely using MRI, reducing uncertainties introduced
when registering images, decreasing the ionising radiation dose received and
improving the patient experience. However, in current practice, the
interstitial needles cannot be visualised by MRI with enough accuracy
(manifested as a high inter-operator variability in the reconstructed needle
positions); therefore the focus of this project was to improve MRI needle
visualisation.Background
The Varian plastic interstitial
needles used (Varian Medical Systems, Palo Alto,
USA) are hollow catheters inserted
into the patient surgically prior to treatment and are where the radioactive
source is inserted in order to give a radiation dose to the tumour. It is
crucial that the needles can be reconstructed accurately in the Varian Eclipse™
Treatment Planning System (TPS) if an MR-only workflow is to be
undertaken. It should be noted that because of the sharp dose fall-off in
brachytherapy, CT electron density information is not required in the same way
as for external beam radiotherapy planning.
Initial work1
on visualisation and reproducibility agreed with our previous work2.
Other centres have investigated this using contrast agents, for example Haack et
al3. used CuSO4 while Otal et al. used
vitamin-A marker points on the template4. Wang et al. used an MR tracking system which consisted of
a stylet with micro-coils
inserted into the catheter5. Zhou et al. also reported on successes at different centres using an
electromagnetic tracking system6. There has been little success on
the visualisation of brachytherapy applicators using sequence development
alone.
Treatment planning for brachytherapy involves
importing images into the TPS and then calculating the positions of the needles
so sources can be placed optimally. This reconstruction needs to be done with
images where the needles are easy to see.
Sequences for MRI treatment planning at this centre are typically
T2-weighted SPACE (TE 96ms, TR 1600ms, 1mm resolution) or T2-TSE (TE 99ms, TR
9930ms, 3mm resolution) which take 3-7 minutes.
Patients are also prone to motion because of the surgery, so any sequence for
identifying the needle positions needs to be fast, high resolution, and
motion-insensitive with the needle artefacts being compact but prominent so
positions can be assessed accurately, while flattening tissue contrast.
This led us to investigate a
proton-density-weighted (PDW) radial volume-interpolated breath-hold excitation
sequence (Star-VIBE; Siemens, Erlangen, Germany).Methods
A combination of phantoms (Eurospin T1,
in-house and fruit) was used to investigate the current imaging sequences (MRI
and CT) and the proposed StarVIBE, with the aim of reducing signal variation in
tissue so that the air cavities inside the needles could be clearly identified.
Optimum flip angles and Signal to Noise ratios (SNR) were found. An in-house
distortion phantom was used to compare reconstructed needle positions in the
TPS on MRI and CT images.
Following the phantom measurements and
analyses, patients were imaged with the standard-of-care method and with the
optimised StarVIBE to compare the sequences, under section 4.3.2.1 (testing sequences)
of the MHRA Safety Guidelines7.
TPS positional errors were measured for three
patients using all the imaging types and by eight operators, and inter-operator
variability was assessed.
All work was conducted using a Siemens Aera
1.5T MRI, and a Siemens Definition planning CT.Results
A comparison of image contrasts on a kiwi
fruit is shown in Figure 1. The Eurospin T1 phantom StarVIBE images are shown
in Figure 2. A PDW StarVIBE sequence using a 2o
flip angle, slice thickness 1.3mm, TE 4.77ms and TR 6.8ms was considered
optimum. This gave good air-to-tissue contrast and SNR, and was acquired
radially in k-space, making it robust to motion artefacts. Initially, 520
out-of-phase radial views were used which led to artefacts at tissue
boundaries. To eliminate these, subsequent data were acquired in-phase and
using 320 radial views to minimise acquisition time. Figure 3 shows an
optimised StarVIBE image and the corresponding CT for an HDR patient.
The accuracy and
variability analysis considered a total of 57 needles in 3 patients. The
results of the inter-operator comparison on StarVIBE and CT images are
summarised in Table 1. The overall mean difference seen using StarVIBE MR was
1.06mm, compared with 0.94mm when CT was used. Both are within the
clinical tolerance of 2mm.
The results from the
inter-operator study show similar inter-operator variability whether needles
are visualised using the MR StarVIBE sequence or CT.Discussion
Using MR-only avoids the uncertainty of the
registration to CT, which could lead to an overall reduction in uncertainty. Furthermore,
an improvement in operators’ ability to reconstruct applicators in the TPS
using MR-only is expected when more experience is gained. There is potential to
implement this method clinically. As this study has been conducted without MRI
contrast or additional equipment this technique could be easily implemented by
other centres. There is potential for a similar sequence to be used for MR-only
I-125 seed low-dose-rate brachytherapy post-planning.Acknowledgements
No acknowledgement found.References
1. Newton V. et al., MR in the Radiotherapy Pathway, IPEM Meeting (2019)
2. Wills,
R. et
al., Applicator reconstruction for HDR
cervix treatment planning using images from 0.35 T open MR scanner Radiother Oncol. 2010 Mar;94(3):346-52
3. Haack S.
et al., Applicator reconstruction in MRI 3D image-based dose planning of
brachytherapy for cervical cancer. Radiother
Oncol. 2009 May;91(2):187-93.
4. Otal A.
et al., A
method to incorporate interstitial components into the TPS gynecologic rigid
applicator library. J Contemp
Brachytherapy. 2017 Feb;9(1):59-65
5. Wang W.
et al., Evaluation of an active magnetic resonance tracking system for
interstitial brachytherapy. Med Phys.
2015 Dec;42(12):7114-21
6. Zhou J. et al.,Review of advanced catheter
technologies in radiation oncology brachytherapy procedures. Cancer Manag Res. 2015 Jul
16;7:199-211
7. Safety
Guidelines for Magnetic Resonance Imaging Equipment in Clinical Use §4.3.2.1, MHRA 2015